Skip to main content

Table 4 The development of individual MS components after 5 years

From: Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study

  Abdominal obesity Hyperglycemia Hypertension Low HDL-C High TG
Whole cohort 317/2350
(13.5%)
578/2350 (24.6%) 489/2350 (20.8%) 228/2350
(9.7%)
673/2350
(28.6%)
Subjects without any MS components at baseline 77/1171
(6.6%)
175/1171
(14.9%)
125/1171
(10.7%)
77/1171
(6.6%)
155/1171
(13.2%)
  1. MS, metabolic syndrome; HDL-C, high density lipoprotein cholesterol; TG, triglyceride